TG Therapeutics, Inc. (TGTX) Financials

Key financial figures for TG Therapeutics, Inc. (Q1 2026).

Revenue

$205M

Net Income

$20M

EPS

$0.14

Total Assets

$1.5B

Operating Cash Flow

-$18M

Full income statement, balance sheet, and cash flow for TG Therapeutics, Inc. on SentiSense.